SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to
Section 13 or 15(d) of
THE SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of Earliest Event Reported): December 20, 2002
| STEMCELLS, INC. |
| (Exact name of registrant as specified in its charter) |
| Delaware | 0-19871 | 94-3078125 | ||
| (State or other jurisdiction of incorporation) | (Commission File Number) | (I.R.S. Employer Identification Number) |
| 3155 Porter Drive Palo Alto, California 94304 |
| (Address, of principal executive offices, including zip code) |
| (650) 475-3100 |
| (Registrant’s Telephone number including area code) |
| Item 5. OTHER EVENTS | ||||||||
| SIGNATURES | ||||||||
| EXHIBIT INDEX | ||||||||
| Press Release, dated December 20, 2002 | ||||||||
Item 5. OTHER EVENTS
StemCells, Inc. (the “Company”) reported that the Nasdaq Stock Market has approved its application to transfer the listing of its common stock from the National Market to the SmallCap Market, effective December 23, 2002 at the opening of business. A copy of the Company’s press release announcing the approval is attached as Exhibit 99.1 to this Report and incorporated herein by this reference.
2
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| STEMCELLS, INC | ||
| By: | /s/ Martin McGlynn Martin McGlynn President and Chief Executive Officer |
|
Date: December 20, 2002
3
EXHIBIT INDEX
99.1 |
Press release dated December 20, 2002 | |||
4